# A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg

> **NCT06965998** · PHASE2,PHASE3 · RECRUITING · sponsor: **Ottawa Hospital Research Institute** · enrollment: 50 (estimated)

## Conditions studied

- SVT
- Thrombosis
- Superficial Vein Thrombosis

## Interventions

- **DRUG:** Full dose rivaroxaban
- **DRUG:** Low dose rivaroxaban
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06965998
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-06
- **Primary completion:** 2026-08
- **Final completion:** 2027-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06965998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06965998, "A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06965998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*